2025
Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance—India, 2018–2020
Tamilzhalagan S, Justin E, Selvaraj A, Venkateswaran K, Sivakumar A, Chittibabu S, McLaughlin H, Moonan P, Smith J, Suba S, Narayanan M, Ho C, Kumar N, Tripathy S, Shanmugam S, Hall-Eidson P, Ranganathan U. Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance—India, 2018–2020. Frontiers In Microbiology 2025, 15: 1515627. PMID: 39845030, PMCID: PMC11750862, DOI: 10.3389/fmicb.2024.1515627.Peer-Reviewed Original ResearchPZA resistancePyrazinamide resistanceMultidrug resistanceDuration of tuberculosis treatmentWhole-genome sequencingPrevalence of mutationsSecond-line drugsPZA-resistant isolatesResistance-conferring mutationsGenome sequenceTB burden countriesLineage 2Genotypic characterizationResistance markersNovel mutationsPhenotypic resistanceMutational diversityDiagnostic accuracyTuberculosis treatmentAntituberculosis drugsCo-resistanceBurden countriesPyrazinamideMutationsTB prevention
2023
“It’s about time they taught us”: a qualitative study evaluating the barriers to finding and screening child contacts under five at risk for TB in Gauteng Province, South Africa from the provider and caregiver perspectives
Munedzimwe F, Chetty-Makkan C, Mukora R, Charalambous S, Turner K, Chihota V. “It’s about time they taught us”: a qualitative study evaluating the barriers to finding and screening child contacts under five at risk for TB in Gauteng Province, South Africa from the provider and caregiver perspectives. BMC Health Services Research 2023, 23: 1415. PMID: 38102646, PMCID: PMC10722712, DOI: 10.1186/s12913-023-10359-0.Peer-Reviewed Original ResearchConceptsTB preventive treatmentTB prevention strategiesIsoniazid preventive therapyTB staffSemi-structured questionnaireTB transmissionFacility staffPrevention strategiesPrimary health clinicsPrevention of tuberculosisEnd TB goalChild contactsYears of ageFacility observationsSemi-structured interview guidePreventive therapyTB preventionTB screeningTB treatmentPreventive servicesPreventive treatmentEkurhuleni DistrictHealth clinicsHigh riskCaregiver perspectivesTabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States
Swartwood N, Testa C, Cohen T, Marks S, Hill A, Beeler Asay G, Cochran J, Cranston K, Randall L, Tibbs A, Horsburgh C, Salomon J, Menzies N. Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States. BMC Medicine 2023, 21: 331. PMID: 37649031, PMCID: PMC10469407, DOI: 10.1186/s12916-023-02785-y.Peer-Reviewed Original ResearchConceptsLatent tuberculosis infectionTB outcomesDistrict of ColumbiaTreatment of LTBIIncremental cost-effectiveness ratioTB incidence rateTuberculosis disease burdenQuality-adjusted life yearsCost-effectiveness ratioPublic health agenciesTB casesTB preventionTB incidenceTuberculosis infectionTB epidemiologyDisease burdenIncidence rateService utilizationAdditional interventionsIncidence projectionsLife yearsDemographic dataSocietal perspectiveHealth agenciesPrevention approaches
2019
Genetic Diversity and Molecular Epidemiology of Mycobacterium tuberculosis in Roraima State, Brazil.
Tatara M, Perdigão J, Viveiros M, Kritski A, Silva K, Sacchi F, de Lima C, Dos Santos P, Diniz J, Almeida Silva P, Gomes P, Gomes M, Cunha E, Lapa E Silva J, Portugal I, Croda J, Andrade M. Genetic Diversity and Molecular Epidemiology of Mycobacterium tuberculosis in Roraima State, Brazil. American Journal Of Tropical Medicine And Hygiene 2019, 101: 774-779. PMID: 31392954, PMCID: PMC6779181, DOI: 10.4269/ajtmh.19-0324.Peer-Reviewed Original ResearchConceptsPopulation-based prospective studyDrug resistanceMolecular epidemiologyResistance profilesRepetitive units-variable numberMTB/RIFDrug susceptibility testDrug resistance profilesTransmission of MtbPublic health policyPhenotypic resistance profilesIsoniazid monoTB preventionProspective studyNew strain typesTB epidemiologyPrimary resistanceHigh prevalenceMTB isolatesProportion methodHealth policyMycobacterium tuberculosisSusceptibility testsTuberculosisVulnerable populationsOpportunities for community health workers to contribute to global efforts to end tuberculosis
Sinha P, Shenoi SV, Friedland GH. Opportunities for community health workers to contribute to global efforts to end tuberculosis. Global Public Health 2019, 15: 474-484. PMID: 31516079, PMCID: PMC7028491, DOI: 10.1080/17441692.2019.1663361.Peer-Reviewed Original Research
2018
Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model
Menzies NA, Cohen T, Hill AN, Yaesoubi R, Galer K, Wolf E, Marks SM, Salomon JA. Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model. American Journal Of Epidemiology 2018, 187: 2011-2020. PMID: 29762657, PMCID: PMC6119121, DOI: 10.1093/aje/kwy094.Peer-Reviewed Original ResearchConceptsTB preventionTB eliminationLatent TB infection (LTBI) screeningTB case detectionHigh-risk populationImportant health benefitsTransmission dynamic modelIncident TBActive TBTuberculosis eliminationInfection testingTB controlTB incidenceEpidemiologic evidenceTB transmissionInfection screeningCase detectionTuberculosis trendsUS populationRisk determinantsHealth benefitsTreatment qualityUnited StatesTreatment activitiesTreatmentCompletion of isoniazid preventive therapy among human immunodeficiency virus positive adults in urban Malawi
Thindwa D, MacPherson P, Choko A, Khundi M, Sambakunsi R, Ngwira L, Kalua T, Webb E, Corbett E. Completion of isoniazid preventive therapy among human immunodeficiency virus positive adults in urban Malawi. The International Journal Of Tuberculosis And Lung Disease 2018, 22: 273-279. PMID: 29471904, PMCID: PMC5824849, DOI: 10.5588/ijtld.17.0370.Peer-Reviewed Original ResearchConceptsIsoniazid preventive therapyHIV-positive adultsPreventive therapySide effectsCompletion of IPTHuman Immunodeficiency Virus-Positive AdultsAntiretroviral treatment statusMedian CD4 countHIV care clinicsProspective cohort studyCluster-randomised trialCells/Random effects logistic regressionIPT completionCD4 countCohort studyTB preventionStudy clinicCare clinicsPresumptive TBStage 3/4Positive adultsTreatment statusCare servicesLogistic regression
2011
Tuberculosis Among Participants in an Academic Global Health Medical Exchange Program
Gardner A, Cohen T, Carter EJ. Tuberculosis Among Participants in an Academic Global Health Medical Exchange Program. Journal Of General Internal Medicine 2011, 26: 841-845. PMID: 21359579, PMCID: PMC3138970, DOI: 10.1007/s11606-011-1669-x.Peer-Reviewed Original ResearchConceptsDirect medical careTST conversionTB infectionBurden countriesMedical careLow tuberculosis (TB) burden countriesTuberculin skin test conversionSkin test conversionTB endemic areasPre-travel preparationTuberculosis burden countriesHigh-burden countriesLength of stayTB educationTB preventionTB screeningTB testingTest conversionPercentage reportingDevelopment of guidelinesInadequate preDemographic characteristicsLonger durationExchange programsCare
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply